Enteral Feeding Devices Market (2026 - 2033) Size, Share & Trends Analysis Report By Product (Giving Set, Enteral Feeding Pump, Enteral Feeding tubes, Enteral Feeding Bags), By Age Group, By Indication, By End-use, By Region, And Segment Forecasts

Enteral Feeding Devices Market Summary

The global enteral feeding devices market size was estimated at USD 4.62 billion in 2025 and is projected to reach USD 7.19 billion by 2033, growing at a CAGR of 5.86% from 2026 to 2033. The growing geriatric population has resulted in increased incidences of diabetes, severe pancreatitis, and other gastrointestinal diseases, which fuel the market growth.

Adoption of the “Feed Early Enteral Diet Adequately for Maximum Effect” (FEED ME) protocol in surgical trauma ICUs in the U.S. enables subsidies on these devices. Technological advancements, such as the introduction of tri-funnel replacement G-tubes and J-tubes with reverse-balloon designs, are also expected to drive the growth of the enteral feeding devices industry during the forecast period.

According to the 2022 data published by the Parkinson's Foundation, the prevalence of Parkinson's disease and other neurological disorders is rising significantly with age, with more than 10 million people worldwide currently living with Parkinson's disease. About 90,000 new cases are diagnosed annually in the U.S as the global elderly population continues to grow, from around 1 billion people aged 60 years and above in 2020 to nearly 1.4 billion by 2030 and projected to reach about 2.1 billion by 2050. Older adults are particularly vulnerable to conditions such as stroke, depression, and dementia, which heighten the risk of malnutrition and frailty due to age-related changes in muscle mass and body composition. These health complications often reduce the ability of elderly individuals to perform Activities of Daily Living (ADLs), thereby increasing the likelihood of falls, injuries, and the need for long-term care support.

The rising prevalence of chronic disease is one of the major factors driving the demand for enteral feeding devices. There has been a constant increase in the prevalence of chronic diseases, such as Alzheimer’s disease, Attention Deficit Hyperactivity Disorder (ADHD), osteoporosis, osteoarthritis, central nervous system disorders, and other diseases, which require clinical dietary management. These devices are highly adopted by the geriatric population who are dealing with chronic conditions for proper intake of nourishment and, thus, fueling the market growth.

According to the November 2023 estimates published by the Centers for Disease Control and Prevention, nearly six in ten adults are living with at least one chronic condition. The increasing prevalence of long-term illnesses such as gastrointestinal disorders, neurological diseases, and cancer has significantly raised the number of hospitalizations and surgical procedures worldwide. This trend is driving higher demand for enteral feeding devices, as these systems are widely used to provide nutritional support to patients unable to consume food orally. In addition, the growing geriatric population, rising incidence of critical care admissions, and increasing preference for home-based nutritional therapy are further accelerating the adoption of enteral feeding devices across hospitals, long-term care facilities, and home healthcare settings.

Market Concentration & Characteristics

The chart illustrates the relationship between market concentration, industry characteristics, and industry participants in the enteral feeding devices market. The x-axis represents the level of industry concentration from low to high. At the same time, the y-axis highlights key factors such as competition, regulatory impact, partnerships and collaborations, degree of innovation, and regional expansion. The market is moderately fragmented with several global manufacturers operating in the industry. Innovation and regulatory impact remain high due to ongoing technological advancements in feeding pumps and stringent medical device approval requirements, while partnerships and collaboration are moderate. Regional expansion is also moderate as companies gradually expand into emerging healthcare markets.

The market has witnessed a medium to high degree of innovation, driven by the development of advanced technologies that improve patient safety, ease of use, and treatment outcomes. Innovations include smart enteral feeding pumps with real-time monitoring, automatic flow adjustments, and compatibility with thickened or blended formulas. These technological advancements are key growth drivers and reflect the market's strong focus on innovation. For instance, in September 2023, Cardinal Health announced the U.S. launch of its Kangaroo OMNI Enteral Feeding Pump, designed to offer enteral nutrition patients more flexible and personalized feeding options throughout their care journey.

"Product innovation plays an essential role in our portfolio lifecycle process. Kangaroo OMNI was designed to help improve the lifestyle of enteral feeding patients and caregivers through ease of use, intelligence, versatility and portability.”

"Kangaroo OMNI provides patients and caregivers with the lightest, smallest and quietest Kangaroo feed and flush enteral feeding pump, while delivering a wider variety of commercially available enteral formulas to the patient."

-Kelley Moffett, senior vice president, Global Medical Products, Medical Segment, Cardinal Health.

M&A activity is medium in the enteral feeding devices industry. Key players are focusing on mergers or acquisitions to expand their market reach and portfolio. For instance, in May 2024, Danone acquired Functional Formularies to strengthen its medical nutrition portfolio in the U.S. M&A is mainly focused on expanding specialized product ranges and patient-centric nutrition offerings rather than consolidating large device manufacturers, keeping activity steady.

The impact of regulations is high, especially in regions such as the U.S. and Europe. Regulatory frameworks such as the FDA’s medical device classification and the European MDR (Medical Device Regulation) influence product design, approval timelines, and market entry. Companies ensure rigorous quality control, biocompatibility testing, and labeling compliance, significantly affecting innovation speed and product rollouts.

Regional expansion in the enteral feeding devices industry is medium, with companies actively entering emerging markets but facing infrastructural and regulatory challenges. In February 2025, Cardinal Health announced the launch of its Kangaroo OMNI Enteral Feeding Pump in Europe, Australia, and New Zealand, expanding global access to advanced ente ral nutrition delivery solutions.

Product Insights

The enteral feeding pump segment held the largest revenue share of 50.2% in 2025, due to its precision in delivering controlled nutrition and fluids to patients who cannot eat naturally. Key drivers include the rising prevalence of chronic conditions, including cancer, neurological disorders, and gastrointestinal diseases, along with an aging global population requiring long-term nutritional support. Technological advancements such as portable and programmable pumps enhance patient convenience and care quality. For instance, Nutricia's Flocare Infinity III pump is lightweight, allowing users to be mobile and independent.

The enteral feeding bags segment is anticipated to expand at a significant CAGR over the forecast period, driven by affordability, ease of use, and rising demand for home-based enteral nutrition. These bags are essential for gravity or pump-assisted feeding, providing a simple, hygienic way to deliver nutrition directly to patients. Key drivers include the increasing prevalence of chronic diseases, a growing elderly population requiring long-term nutritional care, and expanding outpatient and home care settings.

Age Group Insights

The adult age group segment dominated the enteral feeding devices industry with the largest revenue share in 2025, primarily driven by the high prevalence of chronic diseases such as cancer, stroke, neurological disorders, and gastrointestinal conditions that often require long-term nutritional support. In addition, the rising geriatric population, increasing cases of dysphagia, and growing adoption of home-based enteral nutrition therapy have further contributed to the strong demand for enteral feeding devices among adult patients.

The pediatrics segment is anticipated to expand at a significant CAGR during the forecast period, driven by the rising prevalence of congenital disorders, gastrointestinal diseases, and malnutrition among children who require long-term nutritional support. In addition, the rising number of premature births, improvements in neonatal care, and the growing adoption of pediatric-specific feeding tubes and pumps in hospitals and home care settings are further driving the growth of this segment.

End Use Insights

The hospitals segment dominated the enteral feeding devices market in 2025. Growing awareness among healthcare professionals and others regarding hospital-associated malnutrition is one of the significant factors expected to boost the use and demand for enteral feeding devices in hospitals. Moreover, the increasing number of ICU admissions & re-admissions, the rising demand for enteral foods & formulations among critically or severely ill patients, and the rising prevalence of several chronic disorders such as diabetes, cancer, & others are some of the major factors driving market growth.

The home care segment is anticipated to grow at a significant CAGR during the forecast period, driven by the growing preference for home-based healthcare, increasing adoption of home enteral nutrition for patients with chronic illnesses, and the convenience of managing long-term nutritional needs outside hospitals. In addition, advancements in user-friendly feeding devices and rising caregiver awareness of safe and effective home nutrition management are further driving growth in this segment.

Indication Insights

The cancer care segment dominated the market with a revenue share of 27.8% in 2025. Cancer patients, especially those with oral cancer, encounter difficulties with regular food consumption because of side effects from chemotherapy and radiation therapy. The growing use of enteral feeding devices in cancer care, particularly for patients suffering from cancer cachexia and complications related to treatment, played a significant role in driving the dominance of this segment. According to the WHO March 2025 data, oral cancer, which includes cancers of the lip, mouth, and oropharynx, ranks as the 13th most common cancer globally, with an estimated 389,846 new cases and 188,438 deaths reported worldwide in 2022. In addition, the growing global cancer burden and rising adoption of home-based enteral nutrition drive this segment’s growth.

Orphan diseases are expected to grow at the fastest CAGR over the forecast period, driven by increasing regulatory incentives for orphan drug development, rising awareness and diagnosis of rare diseases, expanding clinical research, and growing availability of specialized nutritional and therapeutic solutions for rare disease management.

Regional Insights

The North America enteral feeding devices market held the largest share of 37.0% in 2025. The growing number of premature infants in critical care is a major factor driving the regional market growth. The market is significantly driven by an increase in the geriatric population, which is more susceptible to chronic diseases that result in various disorders such as gastrointestinal disorders, metabolic disorders, and neurological disorders.

U.S. Enteral Feeding Devices Market Trends

The growth of the U.S. enteral feeding devices industry is driven by continuous technological innovation, strong regulatory oversight, and the increasing prevalence of chronic diseases requiring long-term nutritional support. Advanced solutions such as portable enteral feeding pumps and wireless monitoring systems are gaining adoption to enhance patient mobility and care management. For example, the Infinity Orange Enteral Feeding Pump offers Bluetooth-enabled connectivity for mobile applications, enabling real-time monitoring and improving convenience for both pediatric and adult patients requiring enteral nutrition.

Europe Enteral Feeding Devices Market Trends

The enteral feeding devices industry’s growth in Europe is driven by strong regulatory oversight under the EU Medical Device Regulation (MDR) and by high adoption of clinical nutrition across hospitals and home care settings. Market growth is further supported by the increasing prevalence of chronic diseases, cancer, and neurological disorders requiring long-term nutritional support. In addition, leading manufacturers such as Fresenius Kabi, Danone, and B. Braun are expanding their enteral nutrition portfolios through product innovations and strategic partnerships. The increasing adoption of portable and ambulatory feeding pumps for home enteral nutrition (HEN) is also contributing to market expansion across the region.

The UK enteral feeding devices market is supported by the strong presence of home enteral nutrition programs under the National Health Service (NHS) and increasing awareness of clinical nutrition management. Government-supported home care initiatives and integrated care pathways have encouraged the use of portable feeding pumps and enteral nutrition accessories. Companies such as Nutricia, Fresenius Kabi, Avanos Medical, Inc. continue to strengthen their presence through service-based home nutrition programs and product launches aimed at improving patient mobility and ease of use. For instance, in April 2025, Avanos Medical announced that it would assume direct responsibility for the distribution and sales of its MIC-KEY enteral feeding products in the UK starting July 25, 2025. The move aims to strengthen customer engagement, improve product availability, and deliver a more streamlined experience for healthcare providers and patients.

The enteral feeding devices market in Germany is supported by well-established clinical nutrition protocols and a strong medical device manufacturing base. Germany hosts several key players, including B. Braun and Fresenius Kabi, which continue to expand their enteral feeding product portfolios through technological innovation and product upgrades in feeding pumps and enteral access devices. The country also benefits from a well-developed home healthcare infrastructure, enabling broader adoption of enteral feeding solutions outside hospital settings. Growing demand for long-term nutritional support among oncology, neurological, and critical care patients is further driving market expansion.

Asia Pacific Enteral Feeding Devices Market Trends

The Asia Pacific enteral feeding devices industry is expected to witness the fastest CAGR of 6.7% during the forecast period. The region has a large patient base and rapidly growing elderly population, particularly in Japan and China, where the risk of chronic diseases is higher. Increasing prevalence of conditions such as cancer, diabetes, and gastrointestinal disorders, along with higher rates of nutritional deficiencies among the elderly, is expected to drive demand for enteral feeding devices. According to the World Health Organization, severe malnutrition remains a major global concern, further emphasizing the need for improved nutritional support solutions.

The enteral feeding devices market in Japan is supported by the country’s rapidly aging population and high adoption of medical nutrition in hospital and long-term care settings. Technological advancements in compact feeding pumps and strong clinical nutrition practices contribute to steady market development.

The China enteral feeding devices marketis expanding due to improving healthcare infrastructure, rising hospital admissions, and increasing awareness of clinical nutrition. Growing demand for enteral nutrition in critical care and post-surgical recovery is supporting market growth across the country.

Latin America Enteral Feeding Devices Market Trends

The Latin America enteral feeding devices industry is supported by rising healthcare investments, improving hospital infrastructure, and growing awareness of malnutrition management, particularly among cancer and gastrointestinal patients. Although access to specialized care remains limited, the increasing prevalence of chronic disease and advancements in healthcare create opportunities for expansion.

Middle East & Africa Enteral Feeding Devices Market Trends

The Middle East and Africa enteral feeding devices industry is experiencing significant growth, driven by the expansion of advanced healthcare infrastructure in Gulf Cooperation Council (GCC) countries. Regulatory improvements, such as centralized health authority approvals in countries including Saudi Arabia and the UAE, are streamlining device registrations.

Key Enteral Feeding Devices Company Insights

The market is competitive, with key players emphasizing innovation, product variety, and global reach. They invest in developing advanced technologies, such as portable, wireless pumps and patient-friendly tubes, while pursuing partnerships, geographic expansion, and acquisitions to strengthen market share and regulatory compliance.

Recent Developments

• In January 2026, ENvue Medical launched over-the-counter reusable ENFit syringes in the U.S., expanding enteral feeding and medication delivery solutions through online retailers and durable medical equipment supplier channels nationally.

“With the launch of our over-the-counter ENFit syringes, available in institutional and consumer-friendly packaging, we are expanding access to safe, affordable, and standardized enteral delivery tools that support patients, caregivers, and clinicians wherever care is delivered-while remaining aligned with our mission to improve patient experiences and outcomes.”

- Dr. Doron Besser, CEO of ENvue Medical

• In April 2025, Avanos Medical announced it would assume direct sales and distribution of its MIC-KEY enteral feeding products in the UK starting July 2025, strengthening customer engagement and improving product availability across the country.

"As a trusted supplier in the sector, we remain fully committed to delivering the same high level of service to our enteral customers. As we support this transition, our shared priority with Avanos is ensuring continuity of care for patients and healthcare providers who rely on these essential enteral feeding solutions."

- Les Davies, Managing Director at Vygon UK

• In March 2023, Gravitas Medical recently received FDA 510(k) clearance for its Enteric feeding tube system. It features a "smart" nasogastric tube equipped with sensors to track the tube's position and monitor during feeding.

“Our mission is to use technology to replace the current nutrition delivery solutions with an enteral nutrition intelligence platform that helps caregivers make timely decisions for their patients, and this marks the beginning of that transformation.”

- CEO Sahel Sutaria

• In August 2023, Cardinal Health launched its next-generation NTrainerTM System 2.0, a medical device intended to shorten the length of stay in the neonatal intensive care unit (NICU) for premature and newborn infants by assisting them in developing the oral coordination skills necessary for the transition to independent feeding more quickly. The NTrainerTM System gives parents confidence in their newborns' progress and potential for success after discharge by giving clinicians the objective data they need to monitor an infant's development of pre-feeding skills through real-time assessment technology.

"The NTrainer System demonstrates Cardinal Health's investment in innovation to help improve patient outcomes and increase caregiver confidence while providing objective data important for delivering consistent patient care. The NTrainer System will help some of our most vulnerable patients at the beginning of life through the first and only biofeedback device to improve NNS patterns in newborns and infants born prematurely."

- Steve Mason, CEO of Cardinal Health's Medical Segment

Enteral Feeding DevicesMarket Report Scope

Global Enteral Feeding Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global enteral feeding devicesmarket report based on product, age group, indication, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Giving Sets

  • Enteral Feeding Pumps

  • Enteral Feeding tubes

    • Nasogastric Tube

    • Gastrostomy Tube

    • Others

  • Enteral Feeding Bags

  • Percutaneous Endoscopic Gastrostomy Device

  • Low Profile Gastrostomy Device

  • Other Accessories

• Age Group Outlook (Revenue, USD Million, 2021 - 2033)

  • Adults

  • Pediatrics

• Indication Outlook (Revenue, USD Million, 2021 - 2033)

  • Alzheimer’s

  • Nutrition Deficiency

  • Cancer Care

  • Diabetes

  • Chronic Kidney Diseases

  • Orphan Diseases

  • Dysphagia

  • Pain Management

  • Malabsorption/GI Disorder/Diarrhea

  • Others

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals

    • Cardiology

    • Neurology

    • Critical Care (ICU)

    • Oncology

    • Others

  • Home Care

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe     

    • UK

    • Germany

    • France

    • Spain

    • Italy

    • Sweden

    • Norway

    • Denmark

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait